Eleven individuals have recently joined DF/HCC. See below to learn more about these scientists and their research interests. Aditya Bardia, MD, MPH (MGH) ... | [more]
Welcome to Dana-Farber/Harvard Cancer Center
Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.
Announcements
- 5/15 SUSAN SWERLING LECTURES: "The Immune System and Cancer" Posted: 05-10-12
- Register for Bridge Project Thoracic Oncology Workshop Posted: 05-10-12
- 5/14 Bert Vogelstein's Lecture: "Cancer Genomes and their Implications for Research and Patient Management" Posted: 05-07-12
Latest Cancer News
Eleven new members join DF/HCC
DF/HCC Researchers Reinvent Anti-tumor IL-2 Therapy for GVHD
Graft-versus-host disease (GVHD) often occurs after an allogeneic hematopoietic stem cell transplant (HSCT) from a healthy donor is given to treat hematological cancers. The... | [more]
DNA Resource Core
The DNA Resource Core provides access to specialized resources such as rapid and user friendly high-throughput DNA sequencing, a cDNA/RNAi clone repository, and distribution... | [more]
